Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.9 USD | +11.54% | +8.61% | +116.42% |
May. 07 | Transcript : Trevi Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
May. 07 | Trevi Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+116.42% | 183M | |
+16.90% | 124B | |
+17.18% | 109B | |
-7.20% | 23.84B | |
+1.98% | 22.42B | |
-14.29% | 17.5B | |
-6.85% | 16.61B | |
-37.63% | 16.43B | |
+1.90% | 13.4B | |
+24.44% | 11.47B |
- Stock Market
- Equities
- TRVI Stock
- News Trevi Therapeutics, Inc.
- Oppenheimer Adjusts Trevi Therapeutics' Price Target to $12 From $10, Maintains Outperform Rating